相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bevacizumab biosimilars: scientific justification for extrapolation of indications
Barbara Melosky et al.
FUTURE ONCOLOGY (2018)
Antibodies to watch in 2018
Helene Kaplon et al.
MABS (2018)
Obinutuzumab in chronic lymphocytic leukemia: design, development and place in therapy
Othman Al-Sawaf et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Atezolizumab: A novel PD-L1 inhibitor in cancer therapy with a focus in bladder and non-small cell lung cancers
A. Krishnamurthy et al.
DRUGS OF TODAY (2017)
Immunotherapy for non-small cell lung cancer: current concepts and clinical trials
Marissa Mayor et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2016)
Cancer immunotherapy: the beginning of the end of cancer?
Sofia Farkona et al.
BMC MEDICINE (2016)
Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside
Chantal Kuhn et al.
IMMUNOTHERAPY (2016)
Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma
Larysa Sanchez et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Ju Yeon Lee et al.
NATURE COMMUNICATIONS (2016)
Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatment
Hila Magen et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2016)
Harnessing the immune system to improve cancer therapy
Nikos E. Papaioannou et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
Multiple-purpose immunotherapy for cancer
V. I. Seledtsov et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Mechanisms of action of therapeutic antibodies for cancer
J. M. Redman et al.
MOLECULAR IMMUNOLOGY (2015)
Cancer immunotherapy: Strategies for personalization and combinatorial approaches
Vishwanath Sathyanarayanan et al.
MOLECULAR ONCOLOGY (2015)
Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells
Benjamin Boyerinas et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Recent advances in the field of anti-cancer immunotherapy
Henrique Neves et al.
BBA CLINICAL (2015)
Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies - Impact of effector cells
Shan Chung et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential
Parvin F. Peddi et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2014)
The history of monoclonal antibody development - Progress, remaining challenges and future innovations
Justin K. H. Liu
ANNALS OF MEDICINE AND SURGERY (2014)
Primer on tumor immunology and cancer immunotherapy
Timothy J. Harris et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2013)
Novel Antibody-Based Proteins for Cancer Immunotherapy
Jaheli Fuenmayor et al.
Cancers (2011)
Monoclonal antibodies: versatile platforms for cancer immunotherapy
Louis M. Weiner et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Monoclonal antibodies in cancer therapy: 25 years of progress
Robert K. Oldham et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The Role of Complement in the Mechanism of Action of Rituximab for B-Cell Lymphoma: Implications for Therapy
Xuhui Zhou et al.
ONCOLOGIST (2008)
分享论文
